T cell mediated immunity during influenza B virus infections 3962

Abstract Description Influenza virus infections cause significant global morbidity and mortality. While both influenza A (IAV) and B (IBV) virus contribute to seasonal illness, IBV accounts for ∼50% of the influenza deaths in children and has been less studied due to more limited experimental tools and models. Therefore, the aim of this study was to develop a robust murine model for both the Victoria and Yamagata lineages of IBV. After establishing these models, we evaluated immune responses following a sublethal Victoria or Yamagata lineage IBV infection in C57Bl/6 mice. Our results showed that infection with both IBV lineages increased the number of total and antigen-experienced T cells in the lungs. To investigate further the antigen specificity of these T cells, we used in silico analysis and overlapping peptide arrays to ascertain epitopes in the hemagglutinin (HA) and nucleoprotein (NP) of IBV. Our preliminary results have identified two novel H-2b CD8 T cell epitopes in IBV NP, along with several new CD4 T cell epitopes. Further exploration of the T cell response to these epitopes and their role in protection could inform the development of vaccines that induce strong, long-lasting CD8 and CD4 T cell responses in addition to antibodies against IBV. Funding Sources NIH/NIAID R01AI168001, R01AI127565, R01AI141196, R01AI154458, R01AI154598 Topic Categories Viral Immunology (VIR)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2025-11-01
DOI
https://doi.org/10.1093/jimmun/vkaf283.1703
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

T cell mediated immunity during influenza B virus infections 3962

Kevin L. Legge, P. Kahl
The Journal of Immunology
Influenza Virus Research Studies
article

T cell mediated immunity during influenza B virus infections 3962

Kevin L. Legge, P. Kahl
article en

Abstract

Abstract Description Influenza virus infections cause significant global morbidity and mortality. While both influenza A (IAV) and B (IBV) virus contribute to seasonal illness, IBV accounts for ∼50% of the influenza deaths in children and has been less studied due to more limited experimental tools and models. Therefore, the aim of this study was to develop a robust murine model for both the Victoria and Yamagata lineages of IBV. After establishing these models, we evaluated immune responses following a sublethal Victoria or Yamagata lineage IBV infection in C57Bl/6 mice. Our results showed that infection with both IBV lineages increased the number of total and antigen-experienced T cells in the lungs. To investigate further the antigen specificity of these T cells, we used in silico analysis and overlapping peptide arrays to ascertain epitopes in the hemagglutinin (HA) and nucleoprotein (NP) of IBV. Our preliminary results have identified two novel H-2b CD8 T cell epitopes in IBV NP, along with several new CD4 T cell epitopes. Further exploration of the T cell response to these epitopes and their role in protection could inform the development of vaccines that induce strong, long-lasting CD8 and CD4 T cell responses in addition to antibodies against IBV. Funding Sources NIH/NIAID R01AI168001, R01AI127565, R01AI141196, R01AI154458, R01AI154598 Topic Categories Viral Immunology (VIR)

The Journal of ImmunologyVol. 214(Supplement_1)
University of Iowa (US)
Openalex Percentile: Top 54%
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.